Impact of single-dose nandrolone decanoate on gonadotropins, blood lipids and HMG CoA reductase in healthy men.
Détails
ID Serval
serval:BIB_BE0117C0E894
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Impact of single-dose nandrolone decanoate on gonadotropins, blood lipids and HMG CoA reductase in healthy men.
Périodique
Andrologia
ISSN
1439-0272 (Electronic)
ISSN-L
0303-4569
Statut éditorial
Publié
Date de publication
06/2016
Peer-reviewed
Oui
Volume
48
Numéro
5
Pages
595-600
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
The aim was to study the effect and time profile of a single dose of nandrolone decanoate (ND) on gonadotropins, blood lipids and HMG CoA reductase [3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR)] in healthy men. Eleven healthy male participants aged 29-46 years were given a single dose of 150 mg ND as an intramuscular dose of Deca Durabol®, Organon. Blood samples for sex hormones, lipids and HMGCR mRNA analysis were collected prior to ND administration day 0, 4 and 14. A significant suppression of luteinising hormone (LH) and follicle-stimulating hormone (FSH) was seen after 4 days. Total testosterone and bioavailable testosterone level decreased significantly throughout the observed study period. A small but significant decrease in sexual hormone-binding globulin (SHBG) was seen after 4 days but not after 14 days. Total serum (S)-cholesterol and plasma (P)-apolipoprotein B (ApoB) increased significantly after 14 days. In 80% of the individuals, the HMGCR mRNA level was increased 4 days after the ND administration. Our results show that a single dose of 150 mg ND increases (1) HMGCR mRNA expression, (2) total S-cholesterol and (3) P-ApoB level. The long-term consequences on cardiovascular risk that may appear in users remain to be elucidated.
Mots-clé
Adult, Anabolic Agents/administration & dosage, Anabolic Agents/adverse effects, Apolipoproteins B/blood, Cardiovascular Diseases/etiology, Cholesterol/blood, Follicle Stimulating Hormone/blood, Gonadotropins/blood, Humans, Hydroxymethylglutaryl CoA Reductases/genetics, Lipids/blood, Luteinizing Hormone/blood, Male, Middle Aged, Nandrolone/administration & dosage, Nandrolone/adverse effects, Nandrolone/analogs & derivatives, Nandrolone Decanoate, RNA, Messenger/blood, RNA, Messenger/genetics, Risk Factors, Blood lipids, HMG CoA reductase, gonadotropins, nandrolone decanoate
Pubmed
Web of science
Open Access
Oui
Création de la notice
17/12/2020 12:59
Dernière modification de la notice
21/07/2023 12:23